经皮球囊压迫与射频热凝治疗三叉神经痛的回顾性比较
该回顾性单中心分析比较了2002至2019年间230例三叉神经痛患者接受的202次经皮球囊压迫(PBC,46%)与234次射频热凝(RFTC,54%)。两组初始疼痛缓解率无显著差异(PBC 83.7% vs RFTC 84.9%),PBC的无复发生存期在283次手术中长于RFTC(481天 vs 421天,p=0.036)但无统计学显著性。两种干预的并发症率(22.2%)与零死亡率无差异,作者认为应个体化选择并亟需前瞻性对照试验。
要点
- 初始疼痛缓解率PBC 83.7%与RFTC 84.9%无显著差异。
- 多发性硬化(OR 5.34)和较高术前BNI评分(OR 2.01)增加未缓解风险。
- 术后BNI≤II(P<0.0001)和面部麻木评分≥3(p=0.009)与更长无复发生存相关。
核心结论
- 两种经皮干预的初始疼痛缓解和无复发生存期相当,并发症概率低且相当。
- 作者认为应考虑每种干预的优缺点进行个体化决策。
- 作者提出亟需前瞻性对照试验。
研究设计与样本
- 回顾性单中心分析,纳入230例三叉神经痛患者,共接受202次PBC(46%)和234次RFTC(54%),时间跨度为2002至2019年。
- 比较两组人口学数据和三叉神经痛特征,评估初始疼痛缓解(改良BNI疼痛强度量表I-III)、随访至少6个月的无复发生存(Kaplan-Meier分析)、失败初始缓解和无复发生存的风险因素(回归分析)以及并发症和不良事件。
主要发现
- 353次手术(84.2%)实现初始疼痛缓解,PBC组83.7%与RFTC组84.9%之间无显著差异。
- 多发性硬化(OR 5.34)或较高术前BNI评分(OR 2.01)的患者未达到无痛的风险更高。
- 283次手术的无复发生存期:PBC组(44%)481天 vs RFTC组(56%)421天(p=0.036),但无统计学显著性。
- 术后BNI≤II(P<0.0001)和BNI面部麻木评分≥3(p=0.009)是唯一显著影响更长无复发生存率的因素。
- 并发症率为22.2%,死亡率为零,两种手术间无差异(p=0.162)。
临床怎么用
- 作者认为个体化方法应指导决策过程,考虑每种干预的优缺点。
- 作者提出亟需前瞻性对照试验。
局限性
- 原文为回顾性单中心分析。
- 原文报告PBC组无复发生存期481天 vs RFTC组421天(p=0.036)但无统计学显著性。
- 作者在结论中提出亟需前瞻性对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare percutaneous balloon compression (PBC) and radiofrequency thermocoagulation (RFTC) for the treatment of trigeminal neuralgia. METHODS: This was a retrospective single-center analysis of data from 230 patients with trigeminal neuralgia who underwent 202 PBC (46%) and 234 RFTC (54%) from 2002 to 2019. Comparison of demographic data and trigeminal neuralgia characteristics between procedures as well as assessment of 1) initial pain relief by an improved Barrow Neurological Institute (BNI) pain intensity scale of I-III; 2) recurrence-free survival of patients with a follow-up of at least 6 months by Kaplan-Meier analysis; 3) risk factors for failed initial pain relief and recurrence-free survival by regression analysis; and 4) complications and adverse events. RESULTS: Initial pain relief was achieved in 353 (84.2%) procedures and showed no significant difference between PBC (83.7%) and RFTC (84.9%). Patients who suffered from multiple sclerosis (odds ratio 5.34) or had a higher preoperative BNI (odds ratio 2.01) showed a higher risk of not becoming pain free. Recurrence-free survival in 283 procedures was longer for PBC (44%) with 481 days compared to RFTC (56%) with 421 days (p=0.036) but without statistical significance. The only factors that showed a significant influence on longer recurrence-free survival rates were a postoperative BNI ≤ II (P=<0.0001) and a BNI facial numbness score ≥ 3 (p = 0.009). The complication rate of 22.2% as well as zero mortality showed no difference between the two procedures (p=0.162). CONCLUSION: Both percutaneous interventions led to a comparable initial pain relief and recurrence-free survival with a low and comparable probability of complications. An individualized approach, considering the advantages and disadvantages of each intervention, should guide the decision-making process. Prospective comparative trials are urgently needed.
引用
- Herta J, Loidl TB, Schmied T, et al. Retrospective comparison of percutaneous balloon compression and radiofrequency-thermocoagulation in the management of trigeminal neuralgia. Acta Neurochir (Wien). 2023. PMID: 37286804. doi:10.1007/s00701-023-05656-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。